Single Dose of PF-06835919 Escalation Study in Healthy Adult Subjects
NCT02974374
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-alcoholic Fatty Liver Disease
Interventions
DRUG:
PF-06835919
OTHER:
Placebo
Sponsor
Pfizer